| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1006033859 |
| P356 | DOI | 10.1186/1475-2840-3-7 |
| P932 | PMC publication ID | 441397 |
| P698 | PubMed publication ID | 15207013 |
| P5875 | ResearchGate publication ID | 8501139 |
| P50 | author | Jelena Gavrilovic | Q57160155 |
| P2093 | author name string | David A Hughes | |
| Jackie Brown | |||
| Mike Sampson | |||
| Sian Astley | |||
| Brendan Sussams | |||
| Isabel Davies | |||
| P2860 | cites work | A noninvasive method to measure splanchnic glucose uptake after oral glucose administration | Q24629428 |
| Monocyte matrix metalloproteinase production in Type 2 diabetes and controls--a cross sectional study | Q24806823 | ||
| Evaluation of methods for the measurement of low-density lipoprotein cholesterol. | Q29547378 | ||
| Monocyte and neutrophil adhesion molecule expression during acute hyperglycemia and after antioxidant treatment in type 2 diabetes and control patients | Q30836873 | ||
| Increased expression of a scavenger receptor (CD36) in monocytes from subjects with Type 2 diabetes | Q30891442 | ||
| Platelets adhering to the vascular wall mediate postischemic leukocyte-endothelial cell interactions in retinal microcirculation | Q33359763 | ||
| Measurement of matrix metalloproteinases and tissue inhibitors of metalloproteinases in blood and tissues. Clinical and experimental applications | Q33692926 | ||
| Postchallenge plasma glucose and glycemic spikes are more strongly associated with atherosclerosis than fasting glucose or HbA1c level | Q33929071 | ||
| Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques | Q34327535 | ||
| Oxidative stress and diabetic vascular complications | Q34391178 | ||
| Postprandial blood glucose as a risk factor for cardiovascular disease in Type II diabetes: the epidemiological evidence. | Q34495378 | ||
| Biogenesis and exocytosis of Weibel-Palade bodies. | Q34589219 | ||
| Co-expression of ICAM-1, VCAM-1, ELAM-1 and Hsp60 in human arterial and venous endothelial cells in response to cytokines and oxidized low-density lipoproteins | Q40425415 | ||
| Circulating adhesion molecules in humans: role of hyperglycemia and hyperinsulinemia | Q42488027 | ||
| Postprandial endothelial activation in healthy subjects and in type 2 diabetic patients: role of fat and carbohydrate meals. | Q42519503 | ||
| Circulating matrix metalloproteinases and their inhibitors in premature coronary atherosclerosis | Q43659456 | ||
| Elevated matrix metalloproteinase-2 and -9 in urine, but not in serum, are markers of type 1 diabetic nephropathy | Q43687457 | ||
| Effects of diabetes and level of glycemia on all-cause and cardiovascular mortality. The San Antonio Heart Study | Q44049495 | ||
| Increased plasma metalloproteinase-9 concentrations precede development of microalbuminuria in non-insulin-dependent diabetes mellitus. | Q50862383 | ||
| Postprandial low-density lipoproteins in type 2 diabetes are oxidized more extensively than fasting diabetes and control samples. | Q51559965 | ||
| Effects of insulin on in vitro vascular cell adhesion molecule-1 expression and in vivo soluble VCAM-1 release. | Q51560339 | ||
| Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. | Q51679983 | ||
| Oxidized low-density lipoprotein regulates matrix metalloproteinase-9 and its tissue inhibitor in human monocyte-derived macrophages. | Q52534070 | ||
| Elevated matrix metalloproteinase-2 and -3 production from human diabetic dermal fibroblasts. | Q52551463 | ||
| Matrix metalloproteinase 9 (MMP-9/gelatinase B) proteolytically cleaves ICAM-1 and participates in tumor cell resistance to natural killer cell-mediated cytotoxicity. | Q53963339 | ||
| Increased levels of soluble vascular cell adhesion molecule 1 are associated with risk of cardiovascular mortality in type 2 diabetes: the Hoorn study | Q57830053 | ||
| Meal-induced oxidative stress and low-density lipoprotein oxidation in diabetes: The possible role of hyperglycemia | Q58829265 | ||
| Hyperglycemia-induced circulating ICAM-1 increase in diabetes mellitus: the possible role of oxidative stress | Q58829314 | ||
| Soluble forms of E-selectin, ICAM-1 and VCAM-1 are present in the supernatants of cytokine activated cultured endothelial cells | Q67542877 | ||
| Improved measurement of low-density-lipoprotein susceptibility to copper-induced oxidation: application of a short procedure for isolating low-density lipoprotein | Q67904798 | ||
| Modulation by high glucose of adhesion molecule expression in cultured endothelial cells | Q70953778 | ||
| Hepatic blood flow during rapid intravenous glucose tolerance test | Q71415450 | ||
| Expression of VCAM-1 (CD106) by a subset of TCR gamma delta-bearing lymphocyte clones. Involvement of a metalloprotease in the specific hydrolytic release of the soluble isoform | Q71668671 | ||
| Antioxidants inhibit the expression of intercellular cell adhesion molecule-1 and vascular cell adhesion molecule-1 induced by oxidized LDL on human umbilical vein endothelial cells | Q71869353 | ||
| Plasma MMP-9 - a marker of carotid plaque instability | Q73424056 | ||
| Increased oxidation of LDL in patients with coronary artery disease is independent from dietary vitamins E and C | Q73596765 | ||
| Effects of hyperinsulinemia on plasma levels of circulating adhesion molecules | Q73866908 | ||
| Bi-directional induction of matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 during T lymphoma/endothelial cell contact: implication of ICAM-1 | Q74336626 | ||
| The postprandial state and risk of cardiovascular disease | Q77736532 | ||
| Effect of oxidized lipids in the diet on oxidized lipid levels in postprandial serum chylomicrons of diabetic patients | Q77765118 | ||
| Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. The DECODE study group. European Diabetes Epidemiology Group. Diabetes Epidemiology: Collaborative analysis Of Diagnostic criteria in Europe | Q78191116 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | lipoprotein | Q28350 |
| type 2 diabetes | Q3025883 | ||
| P304 | page(s) | 7 | |
| P577 | publication date | 2004-06-18 | |
| P1433 | published in | Cardiovascular Diabetology | Q2468083 |
| P1476 | title | Plasma matrix metalloproteinases, low density lipoprotein oxidisability and soluble adhesion molecules after a glucose load in Type 2 diabetes | |
| P478 | volume | 3 |
| Q35232260 | Blood pressure control predicts plasma matrix metalloproteinase-9 in diabetes mellitus type II. |
| Q39428459 | Hyperglycemia enhances coagulation and reduces neutrophil degranulation, whereas hyperinsulinemia inhibits fibrinolysis during human endotoxemia |
| Q36521250 | Hyperglycemia in acute ischemic stroke: a vascular perspective. |
| Q36675859 | Inflammation in metabolic syndrome and type 2 diabetes: Impact of dietary glucose |
| Q39766035 | Management of cardiac fibrosis in diabetic rats; the role of peroxisome proliferator activated receptor gamma (PPAR-gamma) and calcium channel blockers (CCBs) |
| Q35674048 | Matrix metalloproteinases in type 2 diabetes and non-diabetic controls: effects of short-term and chronic hyperglycaemia |
| Q28573358 | N-acetylcysteine attenuates PKCbeta2 overexpression and myocardial hypertrophy in streptozotocin-induced diabetic rats |
| Q43275703 | Oxidative stress and platelet activation: markers of myocardial infarction in type 2 diabetes mellitus |
| Q53254006 | The impact of acute high-intensity interval exercise on biomarkers of cardiovascular health in type 2 diabetes. |
| Q38061799 | The role of oxidative stress in postprandial endothelial dysfunction |
Search more.